Hyderabad Telangana, India

Muthulingam Arunagiri

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Muthulingam Arunagiri: Innovator in Pharmaceutical Processes

Introduction

Muthulingam Arunagiri is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing important medications. With a total of two patents to his name, Arunagiri's work is recognized for its innovation and practical applications.

Latest Patents

Arunagiri's latest patents include a process for preparing telmisartan, which involves cyclizing 3-amino-4-butyramido-5-methylbenzoic acid to form 2-n-propyl-4-methyl-benzimidazole-6-carboxylic acid. Additionally, he has developed a process for preparing tolterodine with high purity, showcasing his expertise in pharmaceutical chemistry.

Career Highlights

Muthulingam Arunagiri is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality. His role at the company allows him to apply his inventive skills to real-world challenges in drug development.

Collaborations

Arunagiri has collaborated with esteemed colleagues such as Sundaram Venkataraman and Vijayavitthal Thippannachar Mathad. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Muthulingam Arunagiri stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative processes that improve drug formulation. His contributions continue to impact the field positively, demonstrating the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…